Immunology is the latest addition to the expanding portfolio of MBG. Immunologic tests employ an antigen to detect presence of antibodies to a pathogen,
or an antibody to detect the presence of an antigen, of the pathogen in the specimens of the patient. At MBG, we use ECL (Electrochemiluminescence) technology for
immunoassay detection, which results in high sensitivity and specificity.
Validated
Assay Code
HIV-197
Description
SARS-CoV-2, the causative agent of COVID-19, belongs to the genus Betacoronavirus and was firstly identified in humans in January 2020. It is primarily transmitted through droplets released when an infected person coughs, sneezes, or talks in close vicinity to other individuals. People can also become infected by touching surfaces that have been contaminated with the droplets of infected persons. The time from exposure to onset of symptoms is typically around five days but may range from two to 14 days.
Common symptoms include fever, cough, fatigue, shortness of breath, and loss of sense of smell and taste. Complications may include pneumonia, acute respiratory distress syndrome, multi-organ failure, septic shock, and blood clots.
Method
Electrochemiluminescence.
Sample Type
Serum.
Transport Condition
Samples should be transported at 4°C.
Turn Around Time (TAT)
TAT for routine samples is within 1-2 working days.
Samples delivered before 11:00 AM will begin processing immediately resulting in shorter TAT.
Urgent Samples must be delivered before 11:00 AM and will be charged double.
Immunology is the latest addition to the expanding portfolio of MBG. Immunologic tests employ an antigen to detect presence of antibodies to a pathogen,
or an antibody to detect the presence of an antigen, of the pathogen in the specimens of the patient. At MBG, we use ECL (Electrochemiluminescence) technology for
immunoassay detection, which results in high sensitivity and specificity.
Validated
Assay Code
HIV-197
Description
SARS-CoV-2, the causative agent of COVID-19, belongs to the genus Betacoronavirus and was firstly identified in humans in January 2020. It is primarily transmitted through droplets released when an infected person coughs, sneezes, or talks in close vicinity to other individuals. People can also become infected by touching surfaces that have been contaminated with the droplets of infected persons. The time from exposure to onset of symptoms is typically around five days but may range from two to 14 days.
Common symptoms include fever, cough, fatigue, shortness of breath, and loss of sense of smell and taste. Complications may include pneumonia, acute respiratory distress syndrome, multi-organ failure, septic shock, and blood clots.
Method
Electrochemiluminescence.
Sample Type
Serum.
Transport Condition
Samples should be transported at 4°C.
Turn Around Time (TAT)
TAT for routine samples is within 1-2 working days.
Samples delivered before 11:00 AM will begin processing immediately resulting in shorter TAT.
Urgent Samples must be delivered before 11:00 AM and will be charged double.
